home All News open_in_new Full Article

China accepts Hutchmed fanregratinib NDA on single phase II trial

China accepts Hutchmed fanregratinib NDA on single phase II trial  BioWorld MedTech


today 2 w. ago attach_file Politics



ID: 2556926649
Add Watch Country

arrow_drop_down